Gene · 79400
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles in metabolic perspective: mechanism and targeted therapy. | J Nanobiotechnology | 2025 | 41084004 | PubTator, text mining | PubMed |
| Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications. | Cell Death Discov | 2025 | 40855044 | PubTator, text mining | PubMed |
| Metabolic syndrome: molecular mechanisms and therapeutic interventions. | Mol Biomed | 2025 | 40855011 | PubTator, text mining | PubMed |
| Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. | Mol Cancer | 2025 | 40847302 | PubTator, text mining | PubMed |
| Oxidative stress and programmed cell death in diabetic wounds: A comprehensive review. | Sci Prog | 2025 | 40827034 | PubTator, text mining | PubMed |
| Dexmedetomidine Stimulates Cellular Senescence of Lung Cancer Cells Via NOX5. | J Biochem Mol Toxicol | 2025 | 40757447 | PubTator, text mining | PubMed |
| NOX Transmembrane Electron Transfer Is Governed by a Subtly Balanced, Self-Adjusting Charge Distribution. | J Chem Inf Model | 2025 | 40747790 | PubTator, text mining | PubMed |
| Identification of key ferroptosis-related genes associated with the development of gastric cancer: Prognostic models, molecular mechanisms and potential treatment strategies. | Oncol Lett | 2025 | 40747376 | PubTator, text mining | PubMed |
| Potential effects of the tumor microenvironment after BNCT: pro or antitumoral response and bystander effect in colorectal cancer cells. | Int J Radiat Biol | 2025 | 40711846 | PubTator, text mining | PubMed |
| Enhancing Selectivity and Potency of SNAr Covalent Inhibitors of NADPH Oxidase Enzymes. | J Med Chem | 2025 | 40537977 | PubTator, text mining | PubMed |
| Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer. | Cancer Med | 2025 | 40377005 | PubTator, text mining | PubMed |
| Characterising the role of placental angiotensin-converting enzyme 2 (ACE2) during the onset of oxidative insult by hypoxia/reoxygenation: Implications for fetal growth restriction. | Placenta | 2025 | 40222298 | PubTator, text mining | PubMed |
| SET7 lysine methyltransferase mediates the up-regulation of NADPH oxidase expression, oxidative stress, and NLRP3 inflammasome priming in atherosclerosis. | J Transl Med | 2025 | 40098010 | PubTator, text mining | PubMed |
| Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor. | J Med Chem | 2025 | 40042998 | PubTator, text mining | PubMed |
| PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity. | Antioxidants (Basel) | 2025 | 40002359 | PubTator, text mining | PubMed |
| Flavonoids and other constituents from Jacaranda mimosifolia: In vitro analysis, molecular docking, and molecular dynamic simulations of antioxidant and anti-inflammatory activities. | Biomed Pharmacother | 2025 | 39693906 | PubTator, text mining | PubMed |
| Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells. | Front Pharmacol | 2024 | 39850563 | PubTator, text mining | PubMed |
| Association of NOX5 Expression with Sperm Activity and Motility in Pathospermic Infertile Men. | J Reprod Infertil | 2024 | 39830324 | PubTator, text mining | PubMed |
| The Impact of NADPH Oxidase 5 Activity and Reactive Oxygen Species on Capacitated Human Sperm. | J Reprod Infertil | 2024 | 39830321 | PubTator, text mining | PubMed |
| [Inhibition of PRDX1 protein expression and promotion of apoptosis of colorectal cancer cells by furanodienone via inducing ROS generation from NOX4-derived mitochondria]. | Zhongguo Zhong Yao Za Zhi | 2024 | 39701785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79400/papers?page=2